Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 952 | 0 | 0 | 0 | 0 |
| Gross Profit | 952 | N/A | N/A | N/A | N/A |
| Operating Expenses | 43,357 | 47,666 | 36,607 | 27,719 | 26,458 |
| Operating Income | -42,405 | 34,988 | -36,607 | -27,719 | -26,458 |
| Other Income | 221 | 288 | 529 | 995 | 1,572 |
| Pre-tax Income | -42,184 | 35,276 | -36,078 | -26,724 | -24,886 |
| Net Income Continuous | -42,184 | 35,276 | -36,078 | -26,724 | -24,886 |
| Net Income | $-42,184 | $35,276 | $-36,078 | $-26,724 | $-24,886 |
| EPS Basic Total Ops | -0.47 | 9.65 | -3.00 | -6.06 | -5.99 |
| EPS Basic Continuous Ops | -0.47 | 11.33 | -0.51 | -6.06 | -5.99 |
| EPS Diluted Total Ops | -0.47 | 9.65 | -3.00 | -6.06 | -5.99 |
| EPS Diluted Continuous Ops | -0.47 | 11.33 | -0.51 | -6.06 | -5.99 |
| EBITDA(a) | $-41,333 | $-46,740 | $-35,686 | $-26,971 | $-25,920 |